Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study

被引:0
|
作者
C. Senn
B. Günther
A. W. Popp
R. Perrelet
D. Hans
K. Lippuner
机构
[1] Berne University Hospital and University of Berne,Department of Osteoporosis, Inselspital
[2] Lausanne University Hospital,Center of Bone Disease, Bone and Joint Department
来源
关键词
Bone mineral density; Open-label study; Osteoporosis; Parathyroid hormone; Teriparatide; Trabecular bone score; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1945 / 1951
页数:6
相关论文
共 50 条
  • [31] Continued improvements in bone mineral density in women with postmenopausal osteoporosis following 1 and 2 years of intravenous ibandronate therapy.
    Civitelli, R.
    Recknor, C.
    Barr, C. E.
    Lane, N.
    Zaidi, M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S14 - S15
  • [32] Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study
    Ishibashi, Hideaki
    Crittenden, Daria B.
    Miyauchi, Akimitsu
    Libanati, Cesar
    Maddox, Judy
    Fan, Michelle
    Chen, Li
    Grauer, Andreas
    BONE, 2017, 103 : 209 - 215
  • [33] Effects of two years treatment with teriparatide on bone mineral density in women with postmenopausal osteoporosis previously treated with anti-resorptive agents
    Michaud, M.
    CAHIERS DE L ANNEE GERONTOLOGIQUE, 2010, 2 (03): : 159 - 162
  • [34] EFFECT OF TERIPARATIDE ON BONE MINERAL MASS, VOLUMETRIC BONE MINERAL DENSITY AND BONE GEOMETRY IN POSTMENOPAUSAL WOMEN WITH ESTABLISHED OSTEOPOROSIS: A TIBIA PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (PQCT) STUDY
    Stathopoulos, K.
    Damianou, E.
    Bournazos, I.
    Partsinevelos, A.
    Atsali, E.
    Dionysiotis, I.
    Zoubos, A. B.
    Papaggelopoulos, P.
    Skarantavos, G.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S402 - S402
  • [35] Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis
    Ganapathy, Aravinda
    Nieves, Jeri W.
    Keaveny, Tony M.
    Cosman, Felicia
    BONE, 2023, 167
  • [36] Effect of one year treatment with the cathepsin-K inhibitor, balicatib, on bone mineral density (BMD) in postmenopausal women with osteopenia/osteoporosis.
    Adami, S.
    Supronik, J.
    Hala, T.
    Brown, J. P.
    Garnero, P.
    Haemmerle, S.
    Ortmann, C. E.
    Bouisset, F.
    Trechsel, U.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S24 - S24
  • [37] Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
    Eastell, Richard
    Nagase, Shinichi
    Small, Maria
    Boonen, Steven
    Spector, Tim
    Ohyama, Michiyo
    Kuwayama, Tomohiro
    Deacon, Steve
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (02) : 458 - 466
  • [38] Early change in a bone formation biochemical marker correlates with histomorphometric bone formation activity after 2-year teriparatide treatment in postmenopausal women with osteoporosis
    Stepan, J. J.
    Li, J.
    Burr, D. B.
    Michalska, D.
    Dobnig, H.
    Petto, H.
    Sipos, A.
    Pavo, I.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S241 - S241
  • [39] The Effect of Dried Beancurd on Bone Mineral Density in Postmenopausal Chinese Women: A 2-Year Randomized Controlled Trial
    Lei Li
    Meijun Sun
    Jianping Sun
    Hangru Kong
    Wenwen Zhong
    Hong Wang
    Calcified Tissue International, 2019, 105 : 573 - 581
  • [40] The Effect of Dried Beancurd on Bone Mineral Density in Postmenopausal Chinese Women: A 2-Year Randomized Controlled Trial
    Li, Lei
    Sun, Meijun
    Sun, Jianping
    Kong, Hangru
    Zhong, Wenwen
    Wang, Hong
    CALCIFIED TISSUE INTERNATIONAL, 2019, 105 (06) : 573 - 581